- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT06854718
Dor com demência (PWD)
Treinamento de habilidades de enfrentamento de dor assistida por cuidador para estudo piloto de demência
The purpose of the study is to develop a caregiver-assisted pain coping skills training program for older adults who have pain and mild to moderate dementia and are living at home with a family caregiver. The investigators are planning to recruit 30 patient-caregiver dyads (60 individuals).
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Involving caregivers in a pain coping skills protocol is likely to optimize treatment outcomes in several ways.
First, people with dementia (PWD) are likely to have difficulty learning and remembering pain coping skills; training the caregiver to coach the patient in the use of the skills is likely to improve the patients' acquisition and ongoing use of learned skills.
Second, caregiver involvement in pain coping skills training may increase their understanding of how to gauge how much pain the PWD is experiencing and the impact of pain management strategies. This understanding is increasingly important as the patient's disease progresses, and s/he is less able to report pain verbally.
Third, caregiver-assisted pain management training may enhance caregivers' self-confidence for managing the patient's pain.
Finally, by participating in the pain coping skills training protocol, caregivers may learn coping skills (such as relaxation) that can help them manage the stress associated with caring for a PWD and pain which can be significant.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
North Carolina
-
Durham, North Carolina, Estados Unidos, 27705
- Duke University Medical Center
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
Patients:
- Mild or moderate dementia
- Pain on most days for at least 3 months that interferes with function
- Living at home (non-institutional)
- Age ≥ 50
- English Speaking
Caregivers:
- Provides on average at least 4 hours/day of care/assistance to the patient
- Age ≥ 18
- English Speaking
Exclusion Criteria:
Patient and caregivers
- Lacking capacity for interview or unable to provide informed consent/assent.
- Visual or hearing impairments or severe behavioral problems that preclude participation.
- Too sick to participate.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Outro: Patient-Caregiver Dyads
Patient and caregiver dyads will receive five 45-60 minute sessions over 6-8 week period. This will be over videoconference with a masters-level therapist. All sessions will be audio recorded. |
Patient-caregiver dyads will receive five, forty-to-sixty-minute sessions over a six-to-eight-week period with a therapist to learn pain coping skills. These include training caregivers in strategies for assessing patient pain, including nonverbal pain behaviors (e.g., grimacing, bodily tension, labored breathing), which will become increasingly important as the patient's ability to express pain verbally decreases. The therapist will also train the caregiver to coach the patient in the use of the skills during activities that are challenging because of pain. We will focus on increasing positive patient-caregiver interactions and patient engagement in valued activities. Throughout the training, the therapist will help the patient and caregiver learn strategies for fostering regular home practice and application of the skills, identify challenges in using the skills, and find strategies for coping with challenges. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Client Satisfaction Questionnaire
Prazo: Post-intervention (approximately 8 weeks)
|
Caregiver completes. Score range: 1-4; higher score indicates better outcome |
Post-intervention (approximately 8 weeks)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Quality of life in Alzheimer's Disease Caregiver version and Patient version
Prazo: Baseline and post-intervention (approximately 8 weeks)
|
Patient and Caregiver will complete Patient QOL. Score range: 13-52; higher score indicates better outcome |
Baseline and post-intervention (approximately 8 weeks)
|
|
Brief Pain Inventory-Interference Items
Prazo: Baseline and post-intervention (approximately 8 weeks)
|
Patient and Caregiver will complete Patient pain interference. Score range: 0-10; higher score indicates worse outcome |
Baseline and post-intervention (approximately 8 weeks)
|
|
Caregiver Self-Efficacy in Pain Management
Prazo: Baseline and post-intervention (approximately 8 weeks)
|
Caregiver will complete caregiver self-efficacy. Score range: 0-10; higher score indicates better outcome |
Baseline and post-intervention (approximately 8 weeks)
|
|
Numeric pain scale & verbal descriptor
Prazo: Baseline and post-intervention (approximately 8 weeks)
|
Patient will complete patient pain intensity. Score range: 0-19; higher score indicates worse outcome |
Baseline and post-intervention (approximately 8 weeks)
|
|
Checklist of nonverbal pain indicators
Prazo: Baseline and post-intervention (approximately 8 weeks)
|
Caregiver will complete patient pain intensity. Score range: 0-10; higher score indicates worse outcome |
Baseline and post-intervention (approximately 8 weeks)
|
|
Zarit burden interview
Prazo: Baseline and post-intervention (approximately 8 weeks)
|
Caregivers will complete caregiver burden. Score range: 0-88; higher score indicates worse outcome |
Baseline and post-intervention (approximately 8 weeks)
|
|
Caregiver appraisal-satisfaction scale
Prazo: Baseline and post-intervention (approximately 8 weeks)
|
Caregiver will complete caregiver satisfaction. Score range: 0-10; higher score indicates worse outcome |
Baseline and post-intervention (approximately 8 weeks)
|
|
Neuropsychiatric inventory
Prazo: Baseline and post-intervention (approximately 8 weeks)
|
Caregiver will complete patient neuropsychiatry behaviors. Score range: 0-144; higher score indicates worse outcome |
Baseline and post-intervention (approximately 8 weeks)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Laura Porter, Ph.D, Duke University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
- Manifestações Neurológicas
- Doenças Cerebrais
- Doenças do Sistema Nervoso Central
- Doenças do Sistema Nervoso
- Transtornos Mentais, Desordem Mental
- Neoplasias
- Doenças do sistema imunológico
- Neoplasias por Tipo Histológico
- Distúrbios Neurocognitivos
- Doenças Linfáticas
- Distúrbios Linfoproliferativos
- Distúrbios imunoproliferativos
- Linfoma Não-Hodgkin
- Linfoma
- Condições Patológicas, Sinais e Sintomas
- Sinais e sintomas
- Doenças hemic e linfáticas
- Dor
- Linfoma Folicular
- Demência
Outros números de identificação do estudo
- Pro00116129
- 1R61AG088938-01 (Concessão/Contrato do NIH dos EUA)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .